126 related articles for article (PubMed ID: 29981527)
21. Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts.
Schellhaas B; Strobel D; Stumpf M; Ganslmayer M; Pfeifer L; Goertz RS; Neurath MF; Zopf S
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1422-1427. PubMed ID: 30052538
[TBL] [Abstract][Full Text] [Related]
22. Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
Piñero F; Rubinstein F; Marciano S; Fernández N; Silva J; Zambelo Y; Anders M; Zerega A; Ridruejo E; Miguez C; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Rosales C; Romero G; McCormack L; Reggiardo V; Colombato L; Gadano A; Silva M
Dig Dis Sci; 2019 Mar; 64(3):718-728. PubMed ID: 30511199
[TBL] [Abstract][Full Text] [Related]
23. Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma.
Mohsen W; Rodov M; Prakoso E; Charlton B; Bowen DG; Koorey DJ; Shackel NA; McCaughan GW; Strasser SI
World J Gastroenterol; 2017 Apr; 23(15):2763-2770. PubMed ID: 28487614
[TBL] [Abstract][Full Text] [Related]
24. Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands.
van Meer S; de Man RA; Coenraad MJ; Sprengers D; van Nieuwkerk KM; Klümpen HJ; Jansen PL; IJzermans JN; van Oijen MG; Siersema PD; van Erpecum KJ
J Hepatol; 2015 Nov; 63(5):1156-63. PubMed ID: 26100498
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
[TBL] [Abstract][Full Text] [Related]
26. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.
Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW
J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015
[TBL] [Abstract][Full Text] [Related]
27. Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging.
Taouli B; Goh JS; Lu Y; Qayyum A; Yeh BM; Merriman RB; Coakley FV
J Comput Assist Tomogr; 2005; 29(4):425-9. PubMed ID: 16012295
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan.
Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
J Gastroenterol Hepatol; 2011 Dec; 26(12):1765-71. PubMed ID: 21615793
[TBL] [Abstract][Full Text] [Related]
30. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.
Villa E; Critelli R; Lei B; Marzocchi G; Cammà C; Giannelli G; Pontisso P; Cabibbo G; Enea M; Colopi S; Caporali C; Pollicino T; Milosa F; Karampatou A; Todesca P; Bertolini E; Maccio L; Martinez-Chantar ML; Turola E; Del Buono M; De Maria N; Ballestri S; Schepis F; Loria P; Enrico Gerunda G; Losi L; Cillo U
Gut; 2016 May; 65(5):861-9. PubMed ID: 25666192
[TBL] [Abstract][Full Text] [Related]
31. Predictors of long-term survival in hepatocellular carcinomas: A longitudinal follow-up of 108 patients with small tumors.
Chang HC; Lin YM; Yen AM; Chen SL; Wu WY; Chiu SY; Fann JC; Lin YS; Chen HH; Liao CS
Anticancer Res; 2013 Nov; 33(11):5171-8. PubMed ID: 24222166
[TBL] [Abstract][Full Text] [Related]
32. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
33. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular carcinoma in Child-Pugh C cirrhosis: prognostic factors and survival benefit of nontransplant treatments.
Kudo M; Osaki Y; Matsunaga T; Kasugai H; Oka H; Seki T
Dig Dis; 2013; 31(5-6):490-8. PubMed ID: 24281026
[TBL] [Abstract][Full Text] [Related]
35. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
[TBL] [Abstract][Full Text] [Related]
36. A large cohort of patients with hepatocellular carcinoma in a single European centre: aetiology and prognosis now and in a historical cohort.
Ganslmayer M; Hagel A; Dauth W; Zopf S; Strobel D; Müller V; Uder M; Neurath MF; Siebler J
Swiss Med Wkly; 2014 Jan; 144():w13900. PubMed ID: 24452307
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.
Dhooge M; Coriat R; Mir O; Perkins G; Brezault C; Boudou-Rouquette P; Goldwasser F; Chaussade S
Oncology; 2013; 84(1):32-8. PubMed ID: 23076239
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
39. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
40. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
